Dr. Daniel Kelly is Director and one of 4 Co-Founders of Pacific Neuroscience Institute, a multi-specialty group of over 35 physicians working across 9 Centers of Excellence. He is Director of Pacific Brain Tumor Center and Pacific Pituitary Disorders Center at Providence Saint John’s Health Center, and Professor of Neurosurgery at Saint John&#8217;s Cancer Institute. He serves as President &amp; CEO of the PNI Foundation. A recipient of the Southern California SuperDoctors distinction 16 years in a row (2007-2022), Dr. Kelly is considered a world leader in advancing minimally invasive keyhole and endoscopic approaches for brain, skull base and pituitary tumors. With a long-standing commitment to medical education, he has directed a fellowship training program in minimally invasive brain tumor surgery for 15 years, lectures frequently at national and international meetings for physicians and lay audiences and has over 150 peer-reviewed publications. As Institute Director he also oversees development of innovative programs and clinical trials. He helped launch the Pacific Brain Health Center in 2018 focused on cognitive, memory and mood disorders. He was the creative force behind the Pacific Treatment &amp; Research in Psychedelics (TRIP) program established in 2019 and is a co-investigator in clinical trials at TRIP. Dr. Kelly is a graduate of Claremont McKenna College, Georgetown University School of Medicine and completed neurosurgical training in 1993 at George Washington University. In 2021 he also completed the Certificate in Psychedelic-Assisted Therapies and Research at California Institute of Integral Studies. He was Professor of Neurosurgery and Vice-Chief for the UCLA Division of Neurosurgery until 2007 when he joined Saint John’s Health Center.
&nbsp;

Daniel F. Kelly, MD